Our Pipeline
Our focus is to deliver a pipeline of novel, transformative therapeutics to patients suffering from immunological disorders.
90% of TPD Research is undertaken in Oncology.
Significant opportunity to expand to new indications.
Our focus is to deliver a pipeline of novel, transformative therapeutics to patients suffering from immunological disorders.
90% of TPD Research is undertaken in Oncology.
Significant opportunity to expand to new indications.